Caliper Awarded New Task Order for EPA ToxCa...(s ToxCast program which is expected to c...),Health

Date:11/9/2009

s ToxCast program, which is expected to cover the screening of approximately 700 environmental compounds, in contrast to Phase I which covered approximately 320 compounds. The task order we just received involves screening this new compound set against a panel of 81 G-Protein Coupled Receptor (GPCR) assays, which is a subset of Caliper's current ToxCast assay panel of 275 assays in total. The EPA expanded Caliper's original Phase I ToxCast panel of 235 assays in the third quarter with the addition of 40 new kinase and other enzyme assays. All of these new assays are performed on Caliper's LabChip EZ Reader® instrument, which reflects the high quality of data obtained with our LabChip systems," commented David Manyak, Executive Vice President, Drug Discovery Services.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.

The statements in this press release regarding future events, including statements regarding Caliper's expectations regarding its future role in the EPA's ToxCast program, Caliper's belief that its funded activities under the ToxCast program will continue to expand, Caliper's belief that the recently received task order from the EPA will produce strong double-digit growth in its CDAS business unit in 2010, and Caliper's belief
'/>"/>

SOURCE Caliper Life Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
2. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
5. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
6. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
7. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
8. SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders
9. Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea
10. AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
11. Ridge Diagnostics, Inc. Awarded Phase 2 National Science Foundation Grant